Ocular herpes, also known as herpes simplex keratitis, is an eye infection caused by the herpes simplex virus, most often HSV-1. The virus enters the body through mucous membranes or skin, then travels to sensory nerve ganglia-specifically the trigeminal ganglion-and remains inactive until triggered by factors like illness, UV exposure, or stress.
When reactivated, the virus travels back along nerve pathways to the cornea, leading to inflammation, pain, blurred vision, light sensitivity, and sometimes scarring. Left untreated, it can cause permanent vision loss. The condition affects about 1 in 1,000 people annually in the U.S., according to the American Academy of Ophthalmology.
Reactivation is not rare. Up to 90% of adults carry HSV-1, but only a fraction develop ocular symptoms. The risk increases with prior eye trauma, contact lens use, or weakened immunity. Early diagnosis and antiviral treatment reduce long-term complications.
The herpes simplex virus establishes latency in the trigeminal nerve's dorsal root ganglion after initial infection-often during childhood. This latency allows the virus to persist indefinitely without causing symptoms. Reactivation occurs when internal or external triggers disrupt immune surveillance.
Triggers include fever, sun exposure (especially UV-B), surgery, emotional stress, hormonal changes, and immunosuppression due to illness or medications. During reactivation, viral particles travel retrograde along axons to the cornea, where they replicate and cause epithelial or stromal keratitis.
Epithelial keratitis presents as dendritic ulcers visible under fluorescein staining. Stromal keratitis involves deeper tissue inflammation and immune-mediated damage, increasing the risk of scarring and neovascularization. Both forms require prompt medical attention.
There are two primary clinical forms of ocular herpes, differing in location and mechanism:
| Type | Location | Trigger Mechanism | Prevalence |
|---|---|---|---|
| Epithelial keratitis | Corneal surface | Viral replication in epithelial cells | ~60% of cases |
| Stromal keratitis | Deep corneal layers | Immune response to latent virus | ~30% of cases |
| Endotheliitis | Inner corneal layer | Direct viral invasion of endothelium | ~10% of cases |
Epithelial keratitis typically begins with a painful, red eye and a branching ulcer pattern seen under slit-lamp examination. It responds well to topical antivirals like trifluridine or ganciclovir. Stromal keratitis, however, may not show active viral shedding and requires corticosteroids alongside antivirals to control immune-mediated damage.
A key distinction: stromal keratitis is not treated with antivirals alone. Misdiagnosis leads to worsening inflammation. The CDC notes that mismanagement contributes to up to 30% of vision loss cases in recurrent ocular herpes.
Ocular herpes is frequently mistaken for bacterial conjunctivitis or dry eye syndrome. Symptoms like redness, tearing, and light sensitivity overlap, but ocular herpes includes unilateral pain and decreased vision-signs absent in typical conjunctivitis.
Another misconception is that ocular herpes only occurs in people with frequent cold sores. While HSV-1 reactivation in the mouth is common, the virus can affect the eye independently. A 2021 study in *Ophthalmology* found that 40% of patients with ocular herpes had no history of oral lesions.
Some assume that once treated, recurrence is impossible. But recurrence rates are high: approximately 30% within five years after initial episode, per the National Eye Institute. Recurrences often happen without warning and may progress faster than the first attack.
In 2019, a 42-year-old woman presented with persistent eye pain and blurry vision in her left eye. She'd used over-the-counter eye drops for two weeks. Slit-lamp exam revealed a dendritic ulcer. Fluorescein staining confirmed epithelial involvement. She was diagnosed with herpes simplex keratitis after a PCR test detected HSV-1 DNA in a corneal scraping.
She had no history of cold sores. Her immune system was normal. The trigger was likely prolonged sun exposure during a beach vacation. After starting topical trifluridine and oral acyclovir, symptoms resolved in seven days. However, she experienced a recurrence six months later after a stressful work period, requiring another course of treatment.
This case illustrates that ocular herpes can occur without prior oral symptoms and that stress is a significant reactivation factor. It also shows why early diagnosis matters-delayed treatment increases scarring risk.
If you suspect ocular herpes, seek care from an ophthalmologist immediately. Self-treatment with over-the-counter remedies worsens outcomes. Antiviral therapy must begin within 72 hours of symptom onset to prevent irreversible damage.
For those with recurrent episodes, daily suppressive therapy with oral acyclovir reduces recurrence by 70%, according to the American Academy of Ophthalmology. Wearing UV-blocking sunglasses outdoors and managing stress through sleep and mindfulness also lowers reactivation risk.
People with a history of ocular herpes should avoid contact lenses during flare-ups and maintain regular follow-ups. If you've had a cold sore, inform your eye doctor-it's a risk factor even if you don't recall the outbreak.